25 April 2025
25 April 2025
Roche reported flat Q1 sales for its diagnostic division, citing headwinds in China, but reaffirmed the market’s strategic importance.
Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at its US sites.
Subjects in the study were monitored using the LUX-Dx insertable cardiac monitor system to detect arrhythmia recurrence.
Medtronic plans to launch the system across select clinical and academic centres in the country starting this year.
Fluxus' ultrasensitive detection technology will be utilised in developing and validating the test.
CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.
With birth control having lacked sufficient research for decades, millions of people using the contraceptive pill are left unaware of the specific side effects of synthetic hormones.
The patch is composed of a biologically derived poly-4-hydroxybutyrate material.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
